Allogeneic transplant leads to durable remissions in T-cell lymphomasDecember 6, 2020Lymphoma & Plasma Cell DisordersHematologyOncology
ZUMA-5: Axi-cel yields high response rate in indolent NHLDecember 6, 2020Lymphoma & Plasma Cell DisordersHematology
Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggestNovember 25, 2020Genitourinary CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMelanomaOncologyLung Cancer
Circulating miRNA could be a potential biomarker for early diagnosis of MMNovember 24, 2020Multiple MyelomaLymphoma & Plasma Cell DisordersOncology
Pigment traits, sun sensitivity associated with risk of non-Hodgkin lymphomas and chronic lymphocytic leukemiaNovember 24, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMixed Topics
Using telehealth to deliver palliative care to cancer patients November 17, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersOncology
Home care for bortezomib safe and reduces hospital visits in myeloma patientsNovember 11, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Lower BP and better tumor control with drug combo?October 26, 2020Lung CancerBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLymphoma & Plasma Cell DisordersMelanoma
Older age, r/r disease in lymphoma patients tied to increased COVID-19 death rateOctober 20, 2020Lymphoma & Plasma Cell DisordersHematology
The scope of under- and overtreatment in older adults with cancerOctober 1, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Two new protein biomarkers may serve as prognostic indicators for outcomes in CLLSeptember 23, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Survey quantifies COVID-19’s impact on oncologySeptember 20, 2020Breast CancerLung CancerLeukemia, Myelodysplasia, TransplantationHead & Neck/Thyroid CancersGenitourinary CancerMelanomaLymphoma & Plasma Cell Disorders
COVID-19 prompts ‘democratization’ of cancer trialsSeptember 16, 2020Genitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanomaOncology
Statins linked to improved survival in multiple myelomaSeptember 10, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Rate of Clinical Trial Enrollment in Patients Treated for DLBCL Within the Veterans Health AdministrationSeptember 2, 2020OncologyLymphoma & Plasma Cell Disorders
